Author
Listed:
- Alexander Kowar
(German Cancer Research Center (DKFZ)
University of Heidelberg)
- Jonas P. Becker
(German Cancer Research Center (DKFZ)
a partnership between DKFZ and University Hospital)
- Rossella Pizzo
(German Cancer Research Center (DKFZ)
University of Heidelberg)
- Zhiwei Tang
(German Cancer Research Center (DKFZ)
University of Heidelberg)
- Julien Champagne
(The Netherlands Cancer Institute)
- Kathrin Wellach
(University of Heidelberg
German Cancer Research Center (DKFZ)
partner site Heidelberg)
- Kiana Samimi
(University of Heidelberg
German Cancer Research Center (DKFZ)
partner site Heidelberg)
- Ariel Galindo-Albarrán
(University Paris-Saclay)
- Pierre-René Körner
(The Netherlands Cancer Institute)
- Jasmine Montenegro Navarro
(The Netherlands Cancer Institute)
- Andrés Elía
(German Cancer Research Center (DKFZ))
- Fiona Megan Tilghman
(German Cancer Research Center (DKFZ))
- Hanan Sakeer
(German Cancer Research Center (DKFZ))
- Marco Antonio Mendoza-Parra
(University Paris-Saclay)
- Angelika B. Riemer
(German Cancer Research Center (DKFZ)
partner site Heidelberg)
- Reuven Agami
(The Netherlands Cancer Institute)
- Fabricio Loayza-Puch
(German Cancer Research Center (DKFZ))
Abstract
Mitosis is a critical phase of the cell cycle and a vulnerable point where cancer cells can be disrupted, causing cell death and inhibiting tumor growth. Challenges such as drug resistance persist in clinical applications. During mitosis, mRNA translation is generally downregulated, while non-canonical translation of specific transcripts continues. Here, we show that mitotic cancer cells redistribute ribosomes toward the 5′ untranslated region (5′ UTR) and beginning of the coding sequence (CDS), enhancing translation of thousands of upstream open reading frames (uORFs) and upstream overlapping open reading frames (uoORFs). This mitotic induction of uORF/uoORF enriches human leukocyte antigen (HLA) presentation of non-canonical peptides on the surface of cancer cells after mitotic inhibitor treatment. Functional assays indicate these epitopes provoke cancer-cell killing by T cells. Our findings highlight the therapeutic potential of targeting uORF/uoORF-derived epitopes with mitotic inhibitors to enhance immune recognition and tumor cell elimination.
Suggested Citation
Alexander Kowar & Jonas P. Becker & Rossella Pizzo & Zhiwei Tang & Julien Champagne & Kathrin Wellach & Kiana Samimi & Ariel Galindo-Albarrán & Pierre-René Körner & Jasmine Montenegro Navarro & Andrés, 2025.
"Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cells,"
Nature Communications, Nature, vol. 16(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63405-2
DOI: 10.1038/s41467-025-63405-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63405-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.